|
|
|
June 15, 2026 TOP NEWS War update: US and
Iranian officials said they had agreed on a framework to end the war, halt
the US blockade of Iran and reopen the Strait of Hormuz, a preliminary pact
that sent oil prices lower but leaves the future of Iran's nuclear programme to further negotiations. US President Donald
Trump wrote on his Truth Social platform around 5:30 p.m. ET (2130 GMT) on
Sunday. "The Deal with the Islamic Republic of Iran is now
complete," US President Donald Trump wrote on his Truth Social platform
his post came right after Pakistani PM announced the deal. The memorandum of
understanding is scheduled to be formally signed in Switzerland on Friday. In a statement, Iran's
Supreme National Security Council said military operations on all fronts,
including Lebanon, would permanently cease beginning Monday night. There was
no immediate response from Israel, which has maintained that it was not a
party to the US-Iran talks. In a joint statement, the United Kingdom,
Germany, France and Italy said they were prepared to ease sanctions on Iran
in exchange for "clear, verifiable steps" limiting Tehran's nuclear
programme.The Strait of Hormuz will be opening up on
Friday after MOU gets signed on Friday in Geneva. Oil prices fell by 4% to $
82/ barrel following the announcement. Asian markets is cherishing the news
with a strong gap up. All the Asian markets are up in the range of 2 to 5%.
Japan touched its all time
high. Gift nifty indicates a strong gap up of 384 points. Patanjali Foods:
Successfully resolved a tax dispute as the GST demand proceedings initiated
against the company. This decision removes a potential financial liability of
Rs 1352 crore plus interest that was initially claimed by the department. NRB Bearings:
Reduced its promoter pledge from 31.64% to 11.42% after Managing Director Harshbeena Zaveri released 1.96 Cr shares on June 11 and
June 12, 2026. The release followed the pre-payment of loans with Tata
Capital Limited and Aditya Birla Capital Limited. Oswal Pumps: Secured
three Letters of Award from NBPDCL and SBPDCL for 63 MW grid-connected
rooftop solar projects worth Rs 247 crore under PM Surya Ghar – Muft Bijli Yojana, covering 57,492 consumer installations
in Bihar. The CAPEX plus RESCO model project carries a cumulative
revenue opportunity exceeding Rs 500 crore, including Rs 257 crore in
long-term energy supply revenue over a 10-year O&M period, to be
commissioned within 9 months of PPA execution. Powergrid: Declared
the successful bidder under tariff-based competitive bidding (TBCB) to
establish an inter-state transmission system project in Andhra Pradesh. The
project is titled “Transmission system for proposed Green Hydrogen / Green
Ammonia projects in Kakinada area (Phase-I)” and will be developed on a
Build, Own, Operate and Transfer (BOOT) basis. NLC India: State-run NLC India announced
that it has secured a critical mineral block in Telangana. In a regulatory
filing, the company stated that it has been selected as the preferred bidder
in the auction of critical and strategic mineral blocks conducted by the
Ministry of Mines. H.G. Infra Engineering: Received
a Letter of Intent (LOI) from REC Power Development and Consultancy Limited
for the WR-ER Inter-Regional Network Expansion Scheme – Part C transmission
project in Jharkhand. The project will be executed through a tariff-based
competitive bidding process. Financial details were disclosed earlier on May
27, 2026. Dr Reddy's Laboratories : The pharmaceutical
company announced the first-to-market launch of Bosutinib Tablets 400 mg, a
generic equivalent of Bosulif, in the United
States, further expanding its oncology portfolio. Bosutinib Tablets (400 mg)
was a first-to-file product and is eligible for 180 days of generic drug
exclusivity for this strength in the US. Thre sales
in the US for the drug stood at $253.8 million during the latest 12-month
period ended April 2026. MACRO WRAP
OTHER NEWS Ather Energy Fundraising :
Ather Energy's board has greenlit a substantial fundraising plan, aiming to
secure up to Rs 2,500 crore. This significant capital infusion will be
achieved through a combination of equity and convertible securities,
including a Rs 1,500 crore Qualified Institutional Placement and Rs 1,000
crore from various other instruments.The latest
fundraising comes as Ather Energy looks to strengthen its balance sheet and
invest in manufacturing capacity expansion, product development and distribution
amid intensifying competition in India's electric two-wheeler market. The
company had raised primary capital through its initial public offering, but
had indicated that additional capital could be required to support future
growth plans. Auto components: India clears
way for self-driving, safety car tech to reduce road deaths. India has scrapped a licence
requirement for radar sensors. freeing automakers to adopt technology that
helps cars avoid crashes and drive themselves by sensing surrounding objects,
in a bid to make some of the world's deadliest roads safer. In a notice on Thursday, the
government waived the licence requirement for radar sensors operating in the
frequency band from 77GHz to 81 GHz. That lets companies enable the
technology without the government having to separately. Automakers Maruti
Suzuki, Tata Motors and Mahindra & Mahindra, stand to benefit from the
change, as well the suppliers behind them, such as Germany's Bosch and
Continental. Ceinsys Tech: Ceinsys
Tech and its US subsidiary have secured purchase orders worth Rs. 30.1 crore
(US$ 3.16 million) from T Second Inc., USA, for NVMe
drive supply and AI-based geospatial solutions. The orders strengthen the
company’s AI capabilities and overseas business presence. Ipca Labs: The company has signed a global
licensing agreement with BRL to access its proprietary biologics delivery
platform. The partnership will focus on the development of advanced
monoclonal antibody therapies, specifically targeting oncology and
inflammatory diseases. Aurobindo Pharma : The United States Food and Drug Administration (US FDA) inspected Eugia Unit-III, a formulation manufacturing facility of Eugia Pharma Specialities, a wholly owned subsidiary of Aurobindo Pharma, in Telangana from January 27 to February 6, 2026. The inspection concluded with 11 observations. The FDA has now classified the facility's inspection status as "Official Action Indicated" (OAI). |